Journal
VIRUSES-BASEL
Volume 2, Issue 8, Pages 1766-1781Publisher
MDPI
DOI: 10.3390/v2081766
Keywords
influenza virus; neuraminidase inhibitors; sialic acid; RNA polymerase
Categories
Funding
- National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200600015C]
- [U01AI070281]
Ask authors/readers for more resources
While vaccines are the primary public health response to seasonal and pandemic flu, short of a universal vaccine there are inherent limitations to this approach. Antiviral drugs provide valuable alternative options for treatment and prophylaxis of influenza. Here, we will review drugs and drug candidates against influenza with an emphasis on the recent progress of a host-targeting entry-blocker drug candidate, DAS181, a sialidase fusion protein.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available